Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a leading biotechnology firm headquartered in the United States, specialises in molecular diagnostics and innovative testing solutions. Founded in 2013, the company has made significant strides in the industry, particularly with its proprietary CoPrimer technology, which enhances the accuracy and efficiency of diagnostic tests. With a focus on infectious diseases, including COVID-19, Co-Diagnostics has developed a range of unique products that stand out for their reliability and rapid results. The company operates primarily in North America and has expanded its reach globally, establishing a strong market position through strategic partnerships and a commitment to quality. Notable achievements include the successful launch of multiple diagnostic tests that have garnered regulatory approvals, solidifying Co-Diagnostics' reputation as a pioneer in the molecular diagnostics sector.
DitchCarbon Score
How does Co-Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Co-Diagnostics, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Co-Diagnostics, Inc.'s reported carbon emissions
Co-Diagnostics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for recent years, nor do they have specified reduction targets or commitments outlined in their climate initiatives. Without specific emissions figures or reduction goals, it is challenging to assess their climate impact or commitments in detail. However, the absence of data may indicate an opportunity for the company to enhance transparency and engage in climate action initiatives within the biotechnology sector. As the industry increasingly prioritises sustainability, Co-Diagnostics may consider establishing measurable targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Co-Diagnostics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
